Global Creatine Kinase
Global Creatine Kinase

Creatine Kinase Comprehensive Study by Type (Kits & Reagents, Instruments), End-users (Hospitals, Clinics, Diagnostic Laboratories, Academic Research Institutes), Test Type (Colorimetric Assay Based Tests, Enzymatic Tests, Point of Care Tests, ELISA Based Tests, Others) Players and Region - Global Market Outlook to 2025

Creatine Kinase Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Dec 2020 Edition 219 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Creatine Kinase Market?

Creatine kinase is an intracellular enzyme found in the heart, brain, skeletal muscle, and other tissues. It is an enzyme that catalyzes the conversion of phosphocreatine, the energy reservoir for the regeneration of ATP, degrading ATP to ADP. Creatine kinase test may be used to diagnose and monitor muscular injuries and diseases.

The market study is being classified by Type (Kits & Reagents and Instruments) and major geographies with country level break-up.

Abbott Laboratories (United States), BBI Solutions (United States), Beckman Coulter (United States), DiaSys Diagnostic Systems GmbH (Germany), Diazyme Laboratories, Inc. (United States), LSI Medience Corporation (Japan), Randox Laboratories Ltd (United Kingdom), Roche Holding AG (Switzerland), Siemens Healthineers (Germany) and Tosoh India Pvt. Ltd (India) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Creatine Kinase market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Creatine Kinase market by Type, Application and Region.

On the basis of geography, the market of Creatine Kinase has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Prevalence of Chronic Diseases
  • Rise in the Number of Diagnostic Centres and Hospitals

Market Trend
  • Increased Research and Development Activities in Medical Science

Restraints
  • High Initial Investment for Research and Development

Opportunities
  • Government Funding to Enhance Healthcare Facilities
  • Growth in the Healthcare Sector

Challenges
  • Stringent Government Rules and Regulations





Key Target Audience
Creatine Kinase Manufacturers, Emerging Companies, Research Professionals and End-users

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Kits & Reagents
  • Instruments
By End-users
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Academic Research Institutes

By Test Type
  • Colorimetric Assay Based Tests
  • Enzymatic Tests
  • Point of Care Tests
  • ELISA Based Tests
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Chronic Diseases
      • 3.2.2. Rise in the Number of Diagnostic Centres and Hospitals
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Research and Development Activities in Medical Science
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Creatine Kinase, by Type, End-users, Test Type and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Creatine Kinase (Value)
      • 5.2.1. Global Creatine Kinase by: Type (Value)
        • 5.2.1.1. Kits & Reagents
        • 5.2.1.2. Instruments
      • 5.2.2. Global Creatine Kinase by: End-users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Diagnostic Laboratories
        • 5.2.2.4. Academic Research Institutes
      • 5.2.3. Global Creatine Kinase by: Test Type (Value)
        • 5.2.3.1. Colorimetric Assay Based Tests
        • 5.2.3.2. Enzymatic Tests
        • 5.2.3.3. Point of Care Tests
        • 5.2.3.4. ELISA Based Tests
        • 5.2.3.5. Others
      • 5.2.4. Global Creatine Kinase Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Creatine Kinase: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BBI Solutions (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Beckman Coulter (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DiaSys Diagnostic Systems GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Diazyme Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. LSI Medience Corporation (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Randox Laboratories Ltd (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Roche Holding AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Siemens Healthineers (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Tosoh India Pvt. Ltd (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Creatine Kinase Sale, by Type, End-users, Test Type and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Creatine Kinase (Value)
      • 7.2.1. Global Creatine Kinase by: Type (Value)
        • 7.2.1.1. Kits & Reagents
        • 7.2.1.2. Instruments
      • 7.2.2. Global Creatine Kinase by: End-users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Diagnostic Laboratories
        • 7.2.2.4. Academic Research Institutes
      • 7.2.3. Global Creatine Kinase by: Test Type (Value)
        • 7.2.3.1. Colorimetric Assay Based Tests
        • 7.2.3.2. Enzymatic Tests
        • 7.2.3.3. Point of Care Tests
        • 7.2.3.4. ELISA Based Tests
        • 7.2.3.5. Others
      • 7.2.4. Global Creatine Kinase Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Creatine Kinase: by Type(USD Million)
  • Table 2. Creatine Kinase Kits & Reagents , by Region USD Million (2014-2019)
  • Table 3. Creatine Kinase Instruments , by Region USD Million (2014-2019)
  • Table 4. Creatine Kinase: by End-users(USD Million)
  • Table 5. Creatine Kinase Hospitals , by Region USD Million (2014-2019)
  • Table 6. Creatine Kinase Clinics , by Region USD Million (2014-2019)
  • Table 7. Creatine Kinase Diagnostic Laboratories , by Region USD Million (2014-2019)
  • Table 8. Creatine Kinase Academic Research Institutes , by Region USD Million (2014-2019)
  • Table 9. Creatine Kinase: by Test Type(USD Million)
  • Table 10. Creatine Kinase Colorimetric Assay Based Tests , by Region USD Million (2014-2019)
  • Table 11. Creatine Kinase Enzymatic Tests , by Region USD Million (2014-2019)
  • Table 12. Creatine Kinase Point of Care Tests , by Region USD Million (2014-2019)
  • Table 13. Creatine Kinase ELISA Based Tests , by Region USD Million (2014-2019)
  • Table 14. Creatine Kinase Others , by Region USD Million (2014-2019)
  • Table 15. South America Creatine Kinase, by Country USD Million (2014-2019)
  • Table 16. South America Creatine Kinase, by Type USD Million (2014-2019)
  • Table 17. South America Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 18. South America Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 19. Brazil Creatine Kinase, by Type USD Million (2014-2019)
  • Table 20. Brazil Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 21. Brazil Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 22. Argentina Creatine Kinase, by Type USD Million (2014-2019)
  • Table 23. Argentina Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 24. Argentina Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 25. Rest of South America Creatine Kinase, by Type USD Million (2014-2019)
  • Table 26. Rest of South America Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 27. Rest of South America Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 28. Asia Pacific Creatine Kinase, by Country USD Million (2014-2019)
  • Table 29. Asia Pacific Creatine Kinase, by Type USD Million (2014-2019)
  • Table 30. Asia Pacific Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 31. Asia Pacific Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 32. China Creatine Kinase, by Type USD Million (2014-2019)
  • Table 33. China Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 34. China Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 35. Japan Creatine Kinase, by Type USD Million (2014-2019)
  • Table 36. Japan Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 37. Japan Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 38. India Creatine Kinase, by Type USD Million (2014-2019)
  • Table 39. India Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 40. India Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 41. South Korea Creatine Kinase, by Type USD Million (2014-2019)
  • Table 42. South Korea Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 43. South Korea Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 44. Taiwan Creatine Kinase, by Type USD Million (2014-2019)
  • Table 45. Taiwan Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 46. Taiwan Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 47. Australia Creatine Kinase, by Type USD Million (2014-2019)
  • Table 48. Australia Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 49. Australia Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 50. Rest of Asia-Pacific Creatine Kinase, by Type USD Million (2014-2019)
  • Table 51. Rest of Asia-Pacific Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 52. Rest of Asia-Pacific Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 53. Europe Creatine Kinase, by Country USD Million (2014-2019)
  • Table 54. Europe Creatine Kinase, by Type USD Million (2014-2019)
  • Table 55. Europe Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 56. Europe Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 57. Germany Creatine Kinase, by Type USD Million (2014-2019)
  • Table 58. Germany Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 59. Germany Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 60. France Creatine Kinase, by Type USD Million (2014-2019)
  • Table 61. France Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 62. France Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 63. Italy Creatine Kinase, by Type USD Million (2014-2019)
  • Table 64. Italy Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 65. Italy Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 66. United Kingdom Creatine Kinase, by Type USD Million (2014-2019)
  • Table 67. United Kingdom Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 68. United Kingdom Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 69. Netherlands Creatine Kinase, by Type USD Million (2014-2019)
  • Table 70. Netherlands Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 71. Netherlands Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 72. Rest of Europe Creatine Kinase, by Type USD Million (2014-2019)
  • Table 73. Rest of Europe Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 74. Rest of Europe Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 75. MEA Creatine Kinase, by Country USD Million (2014-2019)
  • Table 76. MEA Creatine Kinase, by Type USD Million (2014-2019)
  • Table 77. MEA Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 78. MEA Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 79. Middle East Creatine Kinase, by Type USD Million (2014-2019)
  • Table 80. Middle East Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 81. Middle East Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 82. Africa Creatine Kinase, by Type USD Million (2014-2019)
  • Table 83. Africa Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 84. Africa Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 85. North America Creatine Kinase, by Country USD Million (2014-2019)
  • Table 86. North America Creatine Kinase, by Type USD Million (2014-2019)
  • Table 87. North America Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 88. North America Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 89. United States Creatine Kinase, by Type USD Million (2014-2019)
  • Table 90. United States Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 91. United States Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 92. Canada Creatine Kinase, by Type USD Million (2014-2019)
  • Table 93. Canada Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 94. Canada Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 95. Mexico Creatine Kinase, by Type USD Million (2014-2019)
  • Table 96. Mexico Creatine Kinase, by End-users USD Million (2014-2019)
  • Table 97. Mexico Creatine Kinase, by Test Type USD Million (2014-2019)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Creatine Kinase: by Type(USD Million)
  • Table 109. Creatine Kinase Kits & Reagents , by Region USD Million (2020-2025)
  • Table 110. Creatine Kinase Instruments , by Region USD Million (2020-2025)
  • Table 111. Creatine Kinase: by End-users(USD Million)
  • Table 112. Creatine Kinase Hospitals , by Region USD Million (2020-2025)
  • Table 113. Creatine Kinase Clinics , by Region USD Million (2020-2025)
  • Table 114. Creatine Kinase Diagnostic Laboratories , by Region USD Million (2020-2025)
  • Table 115. Creatine Kinase Academic Research Institutes , by Region USD Million (2020-2025)
  • Table 116. Creatine Kinase: by Test Type(USD Million)
  • Table 117. Creatine Kinase Colorimetric Assay Based Tests , by Region USD Million (2020-2025)
  • Table 118. Creatine Kinase Enzymatic Tests , by Region USD Million (2020-2025)
  • Table 119. Creatine Kinase Point of Care Tests , by Region USD Million (2020-2025)
  • Table 120. Creatine Kinase ELISA Based Tests , by Region USD Million (2020-2025)
  • Table 121. Creatine Kinase Others , by Region USD Million (2020-2025)
  • Table 122. South America Creatine Kinase, by Country USD Million (2020-2025)
  • Table 123. South America Creatine Kinase, by Type USD Million (2020-2025)
  • Table 124. South America Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 125. South America Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 126. Brazil Creatine Kinase, by Type USD Million (2020-2025)
  • Table 127. Brazil Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 128. Brazil Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 129. Argentina Creatine Kinase, by Type USD Million (2020-2025)
  • Table 130. Argentina Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 131. Argentina Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 132. Rest of South America Creatine Kinase, by Type USD Million (2020-2025)
  • Table 133. Rest of South America Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 134. Rest of South America Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 135. Asia Pacific Creatine Kinase, by Country USD Million (2020-2025)
  • Table 136. Asia Pacific Creatine Kinase, by Type USD Million (2020-2025)
  • Table 137. Asia Pacific Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 138. Asia Pacific Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 139. China Creatine Kinase, by Type USD Million (2020-2025)
  • Table 140. China Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 141. China Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 142. Japan Creatine Kinase, by Type USD Million (2020-2025)
  • Table 143. Japan Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 144. Japan Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 145. India Creatine Kinase, by Type USD Million (2020-2025)
  • Table 146. India Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 147. India Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 148. South Korea Creatine Kinase, by Type USD Million (2020-2025)
  • Table 149. South Korea Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 150. South Korea Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 151. Taiwan Creatine Kinase, by Type USD Million (2020-2025)
  • Table 152. Taiwan Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 153. Taiwan Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 154. Australia Creatine Kinase, by Type USD Million (2020-2025)
  • Table 155. Australia Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 156. Australia Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 157. Rest of Asia-Pacific Creatine Kinase, by Type USD Million (2020-2025)
  • Table 158. Rest of Asia-Pacific Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 159. Rest of Asia-Pacific Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 160. Europe Creatine Kinase, by Country USD Million (2020-2025)
  • Table 161. Europe Creatine Kinase, by Type USD Million (2020-2025)
  • Table 162. Europe Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 163. Europe Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 164. Germany Creatine Kinase, by Type USD Million (2020-2025)
  • Table 165. Germany Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 166. Germany Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 167. France Creatine Kinase, by Type USD Million (2020-2025)
  • Table 168. France Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 169. France Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 170. Italy Creatine Kinase, by Type USD Million (2020-2025)
  • Table 171. Italy Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 172. Italy Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 173. United Kingdom Creatine Kinase, by Type USD Million (2020-2025)
  • Table 174. United Kingdom Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 175. United Kingdom Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 176. Netherlands Creatine Kinase, by Type USD Million (2020-2025)
  • Table 177. Netherlands Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 178. Netherlands Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 179. Rest of Europe Creatine Kinase, by Type USD Million (2020-2025)
  • Table 180. Rest of Europe Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 181. Rest of Europe Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 182. MEA Creatine Kinase, by Country USD Million (2020-2025)
  • Table 183. MEA Creatine Kinase, by Type USD Million (2020-2025)
  • Table 184. MEA Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 185. MEA Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 186. Middle East Creatine Kinase, by Type USD Million (2020-2025)
  • Table 187. Middle East Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 188. Middle East Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 189. Africa Creatine Kinase, by Type USD Million (2020-2025)
  • Table 190. Africa Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 191. Africa Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 192. North America Creatine Kinase, by Country USD Million (2020-2025)
  • Table 193. North America Creatine Kinase, by Type USD Million (2020-2025)
  • Table 194. North America Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 195. North America Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 196. United States Creatine Kinase, by Type USD Million (2020-2025)
  • Table 197. United States Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 198. United States Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 199. Canada Creatine Kinase, by Type USD Million (2020-2025)
  • Table 200. Canada Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 201. Canada Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 202. Mexico Creatine Kinase, by Type USD Million (2020-2025)
  • Table 203. Mexico Creatine Kinase, by End-users USD Million (2020-2025)
  • Table 204. Mexico Creatine Kinase, by Test Type USD Million (2020-2025)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Creatine Kinase: by Type USD Million (2014-2019)
  • Figure 5. Global Creatine Kinase: by End-users USD Million (2014-2019)
  • Figure 6. Global Creatine Kinase: by Test Type USD Million (2014-2019)
  • Figure 7. South America Creatine Kinase Share (%), by Country
  • Figure 8. Asia Pacific Creatine Kinase Share (%), by Country
  • Figure 9. Europe Creatine Kinase Share (%), by Country
  • Figure 10. MEA Creatine Kinase Share (%), by Country
  • Figure 11. North America Creatine Kinase Share (%), by Country
  • Figure 12. Global Creatine Kinase share by Players 2019 (%)
  • Figure 13. Global Creatine Kinase share by Players (Top 3) 2019(%)
  • Figure 14. Global Creatine Kinase share by Players (Top 5) 2019(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott Laboratories (United States) Revenue: by Geography 2019
  • Figure 18. BBI Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 19. BBI Solutions (United States) Revenue: by Geography 2019
  • Figure 20. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 21. Beckman Coulter (United States) Revenue: by Geography 2019
  • Figure 22. DiaSys Diagnostic Systems GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 23. DiaSys Diagnostic Systems GmbH (Germany) Revenue: by Geography 2019
  • Figure 24. Diazyme Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Diazyme Laboratories, Inc. (United States) Revenue: by Geography 2019
  • Figure 26. LSI Medience Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 27. LSI Medience Corporation (Japan) Revenue: by Geography 2019
  • Figure 28. Randox Laboratories Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Randox Laboratories Ltd (United Kingdom) Revenue: by Geography 2019
  • Figure 30. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Roche Holding AG (Switzerland) Revenue: by Geography 2019
  • Figure 32. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Siemens Healthineers (Germany) Revenue: by Geography 2019
  • Figure 34. Tosoh India Pvt. Ltd (India) Revenue, Net Income and Gross profit
  • Figure 35. Tosoh India Pvt. Ltd (India) Revenue: by Geography 2019
  • Figure 36. Global Creatine Kinase: by Type USD Million (2020-2025)
  • Figure 37. Global Creatine Kinase: by End-users USD Million (2020-2025)
  • Figure 38. Global Creatine Kinase: by Test Type USD Million (2020-2025)
  • Figure 39. South America Creatine Kinase Share (%), by Country
  • Figure 40. Asia Pacific Creatine Kinase Share (%), by Country
  • Figure 41. Europe Creatine Kinase Share (%), by Country
  • Figure 42. MEA Creatine Kinase Share (%), by Country
  • Figure 43. North America Creatine Kinase Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • BBI Solutions (United States)
  • Beckman Coulter (United States)
  • DiaSys Diagnostic Systems GmbH (Germany)
  • Diazyme Laboratories, Inc. (United States)
  • LSI Medience Corporation (Japan)
  • Randox Laboratories Ltd (United Kingdom)
  • Roche Holding AG (Switzerland)
  • Siemens Healthineers (Germany)
  • Tosoh India Pvt. Ltd (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation